Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 6001-6005, November 1, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fuscoe, J. C.
Right arrow Articles by Albertini, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fuscoe, J. C.
Right arrow Articles by Albertini, R. J.

V(D)J Recombinase-like Activity Mediates hprt Gene Deletion in Human Fetal T-Lymphocytes1

James C. Fuscoe2, Lisa J. Zimmerman, Malcolm J. Lippert, Janice A. Nicklas, J. Patrick O'Neill and Richard J. Albertini

Environmental Health Research and Testing, Inc, Research Triangle Park, North Carolina 27709 [J. C. F., L. J. Z.], and Genetics Laboratory, University of Vermont, Burlington, Vermont 05401 [M. J. L., J. A. N., J. P. O., R. J. A.]

Studies from several laboratories worldwide have developed a large database for in vivo hypoxanthine-guanine phosphoribosyltransferase gene mutations in human T-lymphocytes. Sufficient differences have been found thus far between the spectrum for spontaneous mutations in adults and that observed in the fetus to suggest fundamental differences in in vivo mutagenic mechanisms at these two life stages. In adults, only ~15% of hypoxanthine-guanine phosphoribosyltransferase mutations have structural alterations on Southern blots, while in the fetus 75% of mutations show alterations of which one-half are deletions of exons 2 and 3. We have now sequenced the breakpoint sites for these specific deletions in 18 mutant lymphocyte clones isolated from 13 normal newborns. Three classes of deletions were found. Each class had the same intron 1 breakpoint but a different intron 3 breakpoint. These mutations have all the signatures of a V(D)J recombinase-mediated event (a 5' consensus heptamer, 3' consensus heptamer and nonamer, nibbling, non-germline-encoded nucleotides, P-nucleotides). At the 3' breakpoint of the most common class (comprising 83% of the mutants) a perfect heptamer can be created by postulating a hairpin loop which could attain a Z-DNA configuration. This feature may indicate recombinase preference for certain DNA structures. These results implicate the V(D)J recombinase in illegitimate events causing mutation in this housekeeping gene during T-cell development. Inactivation of genes involved in the control of growth and differentiation (e.g., tumor suppressor genes) by this mechanism may have important implications for cancer development.

1 Supported in part by U.S. Environmental Protection Agency Contract 68-02-4456 (J. C. F., L. J. Z.), U.S. Environmental Protection Agency Cooperative Agreement CR-183565 (J. P. O.), NIH Grant ROI CA30688 (J. A. N., J. P. O., R. J. A.), NIH Grant T32-07122 (M. J. L.), and U.S. Department of Energy Grant FG028760502 (J. A. N., J. P. O., R. J. A.). This article has not been subjected to U.S. Environmental Protection Agency review and therefore does not necessarily reflect the views of the Agency and no official endorsement should be inferred. Mention of trade names or commercial products does not constitute endorsement or recommendation for use. Department of Energy support does not constitute an endorsement by the Department of Energy of the views expressed.

2 To whom requests for reprints should be addressed, at Environmental Health Research and Testing, Inc., P. O. Box 12199, Research Triangle Park, NC 27709.

Received 8/27/91. Accepted 9/16/91.




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. M. Murray, J. P. O'Neill, T. Messier, J. Rivers, V. E. Walker, B. McGonagle, L. Trombley, L. G. Cowell, G. Kelsoe, F. McBlane, et al.
V(D)J Recombinase-Mediated Processing of Coding Junctions at Cryptic Recombination Signal Sequences in Peripheral T Cells during Human Development
J. Immunol., October 15, 2006; 177(8): 5393 - 5404.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. E. Kendall, P. M. Vacek, J. L. Rivers, S. C. Rice, T. L. Messier, and B. A. Finette
Analysis of Genetic Alterations and Clonal Proliferation in Children Treated for Acute Lymphocytic Leukemia.
Cancer Res., September 1, 2006; 66(17): 8455 - 8461.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Sakata, J. Inoue, H. Ohi, H. Kosugi-Okano, Y. Mishima, K. Hatakeyama, O. Niwa, and R. Kominami
Involvement of V(D)J recombinase in the generation of intragenic deletions in the Rit1/Bcl11b tumor suppressor gene in {gamma}-ray-induced thymic lymphomas and in normal thymus of the mouse
Carcinogenesis, June 1, 2004; 25(6): 1069 - 1075.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. L. Wiemels, B. C. Leonard, Y. Wang, M. R. Segal, S. P. Hunger, M. T. Smith, V. Crouse, X. Ma, P. A. Buffler, and S. R. Pine
Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia
PNAS, November 12, 2002; 99(23): 15101 - 15106.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Yoshioka, J. P. O’Neill, P. M. Vacek, and B. A. Finette
Gestational Age and Gender-specific In Utero V(D)J Recombinase-mediated Deletions
Cancer Res., April 1, 2001; 61(8): 3432 - 3438.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
C. J. Williams, I. Grandal, D. J. Vesprini, U. Wojtyra, J. S. Danska, and C. J. Guidos
Irradiation Promotes V(D)J Joining and RAG-Dependent Neoplastic Transformation in SCID T-Cell Precursors
Mol. Cell. Biol., January 15, 2001; 21(2): 400 - 413.
[Abstract] [Full Text]


Home page
BloodHome page
J.-W. Vaandrager, E. Schuuring, K. Philippo, and P. M. Kluin
V(D)J recombinase-mediated transposition of the BCL2 gene to the IGH locus in follicular lymphoma
Blood, September 1, 2000; 96(5): 1947 - 1952.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. A. Agard and S. M. Lewis
Postcleavage Sequence Specificity in V(D)J Recombination
Mol. Cell. Biol., July 15, 2000; 20(14): 5032 - 5040.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
J. L. Wiemels and M. Greaves
Structure and Possible Mechanisms of TEL-AML1 Gene Fusions in Childhood Acute Lymphoblastic Leukemia
Cancer Res., August 1, 1999; 59(16): 4075 - 4082.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
J. Curry, L. Karnaoukhova, G. C. Guenette, and B. W. Glickman
Influence of Sex, Smoking and Age on Human hprt Mutation Frequencies and Spectra
Genetics, July 1, 1999; 152(3): 1065 - 1077.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.